Close

Oppenheimer Upgrades Sarepta Therapeutic (SRPT) to Outperform

May 2, 2016 8:49 AM EDT Send to a Friend
Oppenheimer upgraded Sarepta Therapeutic (NASDAQ: SRPT) from Perform to Outperform with a price target of $60.00.Analyst Christopher Marai commented, "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login